Extendicare (OTCMKTS:EXETF – Get Free Report) is expected to post its resultson Thursday, August 6th. Analysts expect Extendicare to announce earnings of $0.2781 per share and revenue of $399.3230 million for the quarter.
Extendicare Stock Performance
OTCMKTS EXETF opened at $27.31 on Thursday. Extendicare has a fifty-two week low of $8.62 and a fifty-two week high of $28.45. The business has a 50 day moving average price of $24.92 and a two-hundred day moving average price of $21.39.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. TD Securities reissued a “buy” rating on shares of Extendicare in a research report on Monday, May 11th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Extendicare in a report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Extendicare currently has an average rating of “Buy”.
About Extendicare
Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.
Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalitĂ© banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.
Further Reading
- Five stocks we like better than Extendicare
- UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
